Shopping Cart 0
Cart Subtotal
USD 0

Global Small Molecule API Market 2020-2027 by Source (Synthetic, Semi-synthetic, Natural), Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 3600

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4800

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 6000

Details

Global small molecule active pharmaceutical ingredient (API) market will reach USD 266.2 billion by 2027, growing by 7.3% annually over 2020-2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic.

Highlighted with 85 tables and 85 figures, this 165-page report Global Small Molecule API Market 2020-2027 by Source (Synthetic, Semi-synthetic, Natural), Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global small molecule API market in every aspect of the classification from perspectives of Source, Type, Therapeutic Area, Application, Manufacturer Type, and Region.

Based on Source, the global market is segmented into the following sub-markets with annual revenue (USD bn) for 2017-2027 included in each section.

Synthetic API

o Branded Synthetic API

o Generic Synthetic API

Semi-synthetic API

Natural Origin

Based on Type, the global market is segmented into the following sub-markets with annual revenue (USD bn) for 2017-2027 included in each section.

Standard API

High Potency API (HPAPI)

o Branded HPAPI

o Generic HPAPI

Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue (USD bn) for 2017-2027 included in each section.

Infectious Diseases

Oncology

Ophthalmology

Cardiovascular Disorders

Central Nervous System

Respiratory Disorders

Metabolic Diseases

Other Applications

Based on Application, the global market is segmented into the following sub-markets with annual revenue (USD bn) for 2017-2027 included in each section.

o Clinical Use

o Commercial Use

Based on Manufacturer Type, the global market is segmented into the following sub-markets with annual revenue (USD bn) for 2017-2027 included in each section.

Pharmaceutical Companies (also breakdown by region)

CMOs (also breakdown by region)

Geographically, the following regions together with the listed national/local markets are fully investigated:

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

North America (U.S., Canada, and Mexico)

South America (Brazil, Chile, Argentina, Rest of South America)

MEA (UAE, Saudi Arabia, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue (USD bn) are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

Aurobindo Pharma Ltd.

Cambrex Corporation

Catalent, Inc.

Dr. Reddy's Laboratories Ltd.

GlaxoSmithKline plc

Lonza Group

Merck & Co., Inc.

Mylan N.V.

Novartis AG

Pfizer Inc.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Wuxi AppTec Co., Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Table Of Content

Scope

1 Introduction 8

1.1 Industry Definition and Research Scope 8

1.1.1 Industry Definition 8

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 21

2.1 Market Size and Forecast 21

2.1.1 Impact of COVID-19 on World Economy 22

2.1.2 Impact of COVID-19 on the Market 24

2.2 Major Growth Drivers 26

2.3 Market Restraints and Challenges 29

2.4 Emerging Opportunities and Market Trends 32

2.5 Porter's Fiver Forces Analysis 36

3 Segmentation of Global Market by Source 40

3.1 Market Overview by Source 40

3.2 Synthetic API 42

3.2.1 Branded Synthetic API 43

3.2.2 Generic Synthetic API 44

3.3 Semi-synthetic API 45

3.4 Natural Origin 46

4 Segmentation of Global Market by Type 47

4.1 Market Overview by Type 47

4.2 Standard API 49

4.3 High Potency API (HPAPI) 50

4.3.1 Branded HPAPI 51

4.3.2 Generic HPAPI 52

5 Segmentation of Global Market by Therapeutic Area 53

5.1 Market Overview by Therapeutic Area 53

5.2 Infectious Diseases 55

5.3 Oncology 56

5.4 Ophthalmology 57

5.5 Cardiovascular Disorders 58

5.6 Central Nervous System 59

5.7 Respiratory Disorders 60

5.8 Metabolic Diseases 61

5.9 Other Applications 62

6 Segmentation of Global Market by Application 63

6.1 Market Overview by Application 63

6.2 Clinical Use 65

6.3 Commercial Use 66

7 Segmentation of Global Market by Manufacturer Type 67

7.1 Market Overview by Manufacturer Type 67

7.2 Pharmaceutical Companies 69

7.3 CMOs 71

8 Segmentation of Global Market by Region 73

8.1 Geographic Market Overview 2020-2027 73

8.2 North America Market 2020-2027 by Country 77

8.2.1 Overview of North America Market 77

8.2.2 U.S. 80

8.2.3 Canada 84

8.2.4 Mexico 86

8.3 European Market 2020-2027 by Country 88

8.3.1 Overview of European Market 88

8.3.2 UK 91

8.3.3 France 93

8.3.4 Germany 95

8.3.5 Spain 97

8.3.6 Italy 99

8.3.7 Russia 101

8.3.8 Rest of European Market 103

8.4 Asia-Pacific Market 2020-2027 by Country 105

8.4.1 Overview of Asia-Pacific Market 105

8.4.2 China 108

8.4.3 Japan 110

8.4.4 India 113

8.4.5 Australia 115

8.4.6 South Korea 117

8.4.7 Rest of APAC Region 119

8.5 South America Market 2020-2027 by Country 121

8.5.1 Argentina 124

8.5.2 Brazil 126

8.5.3 Chile 128

8.5.4 Rest of South America Market 130

8.6 MEA Market 2020-2027 by Country 131

8.6.1 UAE 134

8.6.2 Saudi Arabia 136

8.6.3 South Africa 138

8.6.4 Other National Markets 140

9 Competitive Landscape 141

9.1 Overview of Key Vendors 141

9.2 New Product Launch, Partnership, Investment, and M&A 144

9.3 Company Profiles 145

Aurobindo Pharma Ltd. 145

Cambrex Corporation 147

Catalent, Inc. 148

Dr. Reddy's Laboratories Ltd. 149

GlaxoSmithKline plc 150

Lonza Group 151

Merck & Co., Inc. 152

Mylan N.V. 153

Novartis AG 154

Pfizer Inc. 155

Sun Pharmaceutical Industries Ltd. 156

Teva Pharmaceutical Industries Ltd. 157

Wuxi AppTec Co., Ltd. 158

10 Investing in Global Market: Risk Assessment and Management 159

10.1 Risk Evaluation of Global Market 159

10.2 Critical Success Factors (CSFs) 162

Related Reports and Products 165


List Of Figure

Figure 1. Research Method Flow Chart 12

Figure 2. Breakdown of Primary Research 14

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 16

Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 18

Figure 5. Global Small Molecule API Market, 2017-2027, USD mn 21

Figure 6. Impact of COVID-19 on Business 24

Figure 7. Primary Drivers and Impact Factors of Global Small Molecule API Market 26

Figure 8. Primary Restraints and Impact Factors of Global Small Molecule API Market 29

Figure 9. Investment Opportunity Analysis 33

Figure 10. Porter's Fiver Forces Analysis of Global Small Molecule API Market 36

Figure 11. Breakdown of Global Small Molecule API Market by Source, 2020-2027, % of Revenue 40

Figure 12. Contribution to Global 2021-2027 Cumulative Revenue by Source, Value (USD mn) and Share (%) 41

Figure 13. Global Small Molecule API Market: Synthetic API, 2017-2027, USD mn 42

Figure 14. Global Small Molecule API Market: Branded Synthetic API, 2017-2027, USD mn 43

Figure 15. Global Small Molecule API Market: Generic Synthetic API, 2017-2027, USD mn 44

Figure 16. Global Small Molecule API Market: Semi-synthetic API, 2017-2027, USD mn 45

Figure 17. Global Small Molecule API Market: Natural Origin, 2017-2027, USD mn 46

Figure 18. Breakdown of Global Small Molecule API Market by Type, 2020-2027, % of Revenue 47

Figure 19. Contribution to Global 2021-2027 Cumulative Revenue by Type, Value (USD mn) and Share (%) 48

Figure 20. Global Small Molecule API Market: Standard API, 2017-2027, USD mn 49

Figure 21. Global Small Molecule API Market: High Potency API (HPAPI), 2017-2027, USD mn 50

Figure 22. Global Small Molecule API Market: Branded HPAPI, 2017-2027, USD mn 51

Figure 23. Global Small Molecule API Market: Generic HPAPI, 2017-2027, USD mn 52

Figure 24. Breakdown of Global Small Molecule API Market by Therapeutic Area, 2020-2027, % of Revenue 54

Figure 25. Contribution to Global 2021-2027 Cumulative Revenue by Therapeutic Area, Value (USD mn) and Share (%) 54

Figure 26. Global Small Molecule API Market: Infectious Diseases, 2017-2027, USD mn 55

Figure 27. Global Small Molecule API Market: Oncology, 2017-2027, USD mn 56

Figure 28. Global Small Molecule API Market: Ophthalmology , 2017-2027, USD mn 57

Figure 29. Global Small Molecule API Market: Cardiovascular Disorders, 2017-2027, USD mn 58

Figure 30. Global Small Molecule API Market: Central Nervous System, 2017-2027, USD mn 59

Figure 31. Global Small Molecule API Market: Respiratory Disorders, 2017-2027, USD mn 60

Figure 32. Global Small Molecule API Market: Metabolic Diseases, 2017-2027, USD mn 61

Figure 33. Global Small Molecule API Market: Other Applications, 2017-2027, USD mn 62

Figure 34. Breakdown of Global Small Molecule API Market by Application, 2020-2027, % of Revenue 63

Figure 35. Contribution to Global 2021-2027 Cumulative Revenue by Application, Value (USD mn) and Share (%) 64

Figure 36. Global Small Molecule API Market: Clinical Use, 2017-2027, USD mn 65

Figure 37. Global Small Molecule API Market: Commercial Use, 2017-2027, USD mn 66

Figure 38. Breakdown of Global Small Molecule API Market by Manufacturer Type, 2020-2027, % of Revenue 67

Figure 39. Contribution to Global 2021-2027 Cumulative Revenue by Manufacturer Type, Value (USD mn) and Share (%) 68

Figure 40. Global Small Molecule API Market: Pharmaceutical Companies, 2017-2027, USD mn 69

Figure 41. Breakdown of Global Small Molecule API In-house Synthesis Market by Region, 2020-2027, % of Revenue 70

Figure 42. Global Small Molecule API Market: CMOs, 2017-2027, USD mn 71

Figure 43. Breakdown of Global Small Molecule API Contract Synthesis Market by Region, 2020-2027, % of Revenue 72

Figure 44. Global Market Snapshot by Region 73

Figure 45. Geographic Spread of Worldwide Small Molecule API Market, 2020-2027, % of Revenue 74

Figure 46. Contribution to Global 2021-2027 Cumulative Revenue by Region, Value (USD mn) and Share (%) 75

Figure 47. North American Small Molecule API Market, 2017-2027, USD mn 78

Figure 48. Breakdown of North America Small Molecule API Market by Country, 2020 and 2027, % of Revenue 78

Figure 49. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 79

Figure 50. U.S. Small Molecule API Market, 2017-2027, USD mn 81

Figure 51. Canada Small Molecule API Market, 2017-2027, USD mn 84

Figure 52. Small Molecule API Market in Mexico, 2017-2027, USD mn 86

Figure 53. European Small Molecule API Market, 2017-2027, USD mn 89

Figure 54. Breakdown of European Small Molecule API Market by Country, 2020 and 2027, % of Revenue 89

Figure 55. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 90

Figure 56. Small Molecule API Market in UK, 2017-2027, USD mn 91

Figure 57. Small Molecule API Market in France, 2017-2027, USD mn 93

Figure 58. Small Molecule API Market in Germany, 2017-2027, USD mn 95

Figure 59. Small Molecule API Market in Spain, 2017-2027, USD mn 97

Figure 60. Small Molecule API Market in Italy, 2017-2027, USD mn 99

Figure 61. Small Molecule API Market in Russia, 2017-2027, USD mn 101

Figure 62. Small Molecule API Market in Rest of Europe, 2017-2027, USD mn 103

Figure 63. Asia-Pacific Small Molecule API Market, 2017-2027, USD mn 106

Figure 64. Breakdown of APAC Small Molecule API Market by Country, 2020 and 2027, % of Revenue 106

Figure 65. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 107

Figure 66. Small Molecule API Market in China, 2017-2027, USD mn 108

Figure 67. Small Molecule API Market in Japan, 2017-2027, USD mn 111

Figure 68. Small Molecule API Market in India, 2017-2027, USD mn 113

Figure 69. Small Molecule API Market in Australia, 2017-2027, USD mn 115

Figure 70. Small Molecule API Market in South Korea, 2017-2027, USD mn 117

Figure 71. Small Molecule API Market in Rest of APAC, 2017-2027, USD mn 119

Figure 72. South America Small Molecule API Market, 2017-2027, USD mn 122

Figure 73. Breakdown of South America Small Molecule API Market by Country, 2020 and 2027, % of Revenue 122

Figure 74. Contribution to South America 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 123

Figure 75. Small Molecule API Market in Argentina, 2017-2027, USD mn 124

Figure 76. Small Molecule API Market in Brazil, 2017-2027, USD mn 126

Figure 77. Small Molecule API Market in Chile, 2017-2027, USD mn 128

Figure 78. Small Molecule API Market in Rest of South America, 2017-2027, USD mn 130

Figure 79. Small Molecule API Market in Middle East and Africa (MEA), 2017-2027, USD mn 132

Figure 80. Breakdown of MEA Small Molecule API Market by Country, 2020 and 2027, % of Revenue 132

Figure 81. Contribution to MEA 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 133

Figure 82. Small Molecule API Market in UAE, 2017-2027, USD mn 134

Figure 83. Small Molecule API Market in Saudi Arabia, 2017-2027, USD mn 136

Figure 84. Small Molecule API Market in South Africa, 2017-2027, USD mn 138

Figure 85. Growth Stage of Global Small Molecule API Industry over the Forecast Period 141


List Of Table

Table 1. Snapshot of Global Small Molecule API Market in Balanced Perspective, 2020-2027 19

Table 2. Growth Rate of World GDP, 2020-2022 23

Table 3. Main Product Trends and Market Opportunities in Global Small Molecule API Market 32

Table 4. Global Small Molecule API Market by Source, 2017-2027, USD mn 40

Table 5. Global Small Molecule API Market: Synthetic API by Drug Type, 2017-2027, USD mn 42

Table 6. Global Small Molecule API Market by Type, 2017-2027, USD mn 47

Table 7. Global Small Molecule API Market: HPAPI by Drug Type, 2017-2027, USD mn 50

Table 8. Global Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 53

Table 9. Global Small Molecule API Market by Application, 2017-2027, USD mn 63

Table 10. Global Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 67

Table 11. Global Small Molecule API Market by Region, 2017-2027, USD mn 74

Table 12. Leading National Small Molecule API Market, 2020 and 2027, USD mn 76

Table 13. North America Small Molecule API Market by Country, 2017-2027, USD mn 79

Table 14. U.S. Small Molecule API Market by Type, 2017-2027, USD mn 82

Table 15. U.S. Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 82

Table 16. U.S. Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 82

Table 17. Canada Small Molecule API Market by Type, 2017-2027, USD mn 85

Table 18. Canada Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 85

Table 19. Canada Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 85

Table 20. Mexico Small Molecule API Market by Type, 2017-2027, USD mn 87

Table 21. Mexico Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 87

Table 22. Mexico Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 87

Table 23. Europe Small Molecule API Market by Country, 2017-2027, USD mn 90

Table 24. UK Small Molecule API Market by Type, 2017-2027, USD mn 92

Table 25. UK Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 92

Table 26. UK Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 92

Table 27. France Small Molecule API Market by Type, 2017-2027, USD mn 94

Table 28. France Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 94

Table 29. France Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 94

Table 30. Germany Small Molecule API Market by Type, 2017-2027, USD mn 96

Table 31. Germany Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 96

Table 32. Germany Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 96

Table 33. Spain Small Molecule API Market by Type, 2017-2027, USD mn 98

Table 34. Spain Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 98

Table 35. Spain Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 98

Table 36. Italy Small Molecule API Market by Type, 2017-2027, USD mn 100

Table 37. Italy Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 100

Table 38. Italy Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 100

Table 39. Russia Small Molecule API Market by Type, 2017-2027, USD mn 102

Table 40. Russia Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 102

Table 41. Russia Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 102

Table 42. Small Molecule API Market in Rest of Europe by Country, 2017-2027, USD mn 104

Table 43. APAC Small Molecule API Market by Country, 2017-2027, USD mn 107

Table 44. China Small Molecule API Market by Type, 2017-2027, USD mn 109

Table 45. China Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 109

Table 46. China Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 109

Table 47. Japan Small Molecule API Market by Type, 2017-2027, USD mn 112

Table 48. Japan Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 112

Table 49. Japan Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 112

Table 50. India Small Molecule API Market by Type, 2017-2027, USD mn 114

Table 51. India Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 114

Table 52. India Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 114

Table 53. Australia Small Molecule API Market by Type, 2017-2027, USD mn 116

Table 54. Australia Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 116

Table 55. Australia Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 116

Table 56. South Korea Small Molecule API Market by Type, 2017-2027, USD mn 118

Table 57. South Korea Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 118

Table 58. South Korea Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 118

Table 59. Small Molecule API Market in Rest of APAC by Country/Region, 2017-2027, USD mn 120

Table 60. South America Small Molecule API Market by Country, 2017-2027, USD mn 123

Table 61. Argentina Small Molecule API Market by Type, 2017-2027, USD mn 125

Table 62. Argentina Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 125

Table 63. Argentina Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 125

Table 64. Brazil Small Molecule API Market by Type, 2017-2027, USD mn 127

Table 65. Brazil Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 127

Table 66. Brazil Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 127

Table 67. Chile Small Molecule API Market by Type, 2017-2027, USD mn 129

Table 68. Chile Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 129

Table 69. Chile Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 129

Table 70. MEA Small Molecule API Market by Country, 2017-2027, USD mn 133

Table 71. UAE Small Molecule API Market by Type, 2017-2027, USD mn 135

Table 72. UAE Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 135

Table 73. UAE Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 135

Table 74. Saudi Arabia Small Molecule API Market by Type, 2017-2027, USD mn 137

Table 75. Saudi Arabia Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 137

Table 76. Saudi Arabia Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 137

Table 77. South Africa Small Molecule API Market by Type, 2017-2027, USD mn 139

Table 78. South Africa Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 139

Table 79. South Africa Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 139

Table 80. Aurobindo Pharma Ltd.: Company Snapshot 145

Table 81. Aurobindo Pharma Ltd.: Business Segmentation 145

Table 82. Aurobindo Pharma Ltd.: Product Portfolio 146

Table 83. Aurobindo Pharma Ltd.: Revenue, 2017-2019, USD mn 146

Table 84. Risk Evaluation for Investing in Global Market, 2020-2027 160

Table 85. Critical Success Factors and Key Takeaways 163

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Aurobindo Pharma Ltd.

Cambrex Corporation

Catalent, Inc.

Dr. Reddy's Laboratories Ltd.

GlaxoSmithKline plc

Lonza Group

Merck & Co., Inc.

Mylan N.V.

Novartis AG

Pfizer Inc.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Wuxi AppTec Co., Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Company Profile

Company Profile Title

Global small molecule active pharmaceutical ingredient (API) market will reach USD 266.2 billion by 2027, growing by 7.3% annually over 2020-2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic.

Highlighted with 85 tables and 85 figures, this 165-page report Global Small Molecule API Market 2020-2027 by Source (Synthetic, Semi-synthetic, Natural), Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global small molecule API market in every aspect of the classification from perspectives of Source, Type, Therapeutic Area, Application, Manufacturer Type, and Region.

Based on Source, the global market is segmented into the following sub-markets with annual revenue (USD bn) for 2017-2027 included in each section.

Synthetic API

o Branded Synthetic API

o Generic Synthetic API

Semi-synthetic API

Natural Origin

Based on Type, the global market is segmented into the following sub-markets with annual revenue (USD bn) for 2017-2027 included in each section.

Standard API

High Potency API (HPAPI)

o Branded HPAPI

o Generic HPAPI

Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue (USD bn) for 2017-2027 included in each section.

Infectious Diseases

Oncology

Ophthalmology

Cardiovascular Disorders

Central Nervous System

Respiratory Disorders

Metabolic Diseases

Other Applications

Based on Application, the global market is segmented into the following sub-markets with annual revenue (USD bn) for 2017-2027 included in each section.

o Clinical Use

o Commercial Use

Based on Manufacturer Type, the global market is segmented into the following sub-markets with annual revenue (USD bn) for 2017-2027 included in each section.

Pharmaceutical Companies (also breakdown by region)

CMOs (also breakdown by region)

Geographically, the following regions together with the listed national/local markets are fully investigated:

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

North America (U.S., Canada, and Mexico)

South America (Brazil, Chile, Argentina, Rest of South America)

MEA (UAE, Saudi Arabia, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue (USD bn) are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

Aurobindo Pharma Ltd.

Cambrex Corporation

Catalent, Inc.

Dr. Reddy's Laboratories Ltd.

GlaxoSmithKline plc

Lonza Group

Merck & Co., Inc.

Mylan N.V.

Novartis AG

Pfizer Inc.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Wuxi AppTec Co., Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Scope

1 Introduction 8

1.1 Industry Definition and Research Scope 8

1.1.1 Industry Definition 8

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 21

2.1 Market Size and Forecast 21

2.1.1 Impact of COVID-19 on World Economy 22

2.1.2 Impact of COVID-19 on the Market 24

2.2 Major Growth Drivers 26

2.3 Market Restraints and Challenges 29

2.4 Emerging Opportunities and Market Trends 32

2.5 Porter's Fiver Forces Analysis 36

3 Segmentation of Global Market by Source 40

3.1 Market Overview by Source 40

3.2 Synthetic API 42

3.2.1 Branded Synthetic API 43

3.2.2 Generic Synthetic API 44

3.3 Semi-synthetic API 45

3.4 Natural Origin 46

4 Segmentation of Global Market by Type 47

4.1 Market Overview by Type 47

4.2 Standard API 49

4.3 High Potency API (HPAPI) 50

4.3.1 Branded HPAPI 51

4.3.2 Generic HPAPI 52

5 Segmentation of Global Market by Therapeutic Area 53

5.1 Market Overview by Therapeutic Area 53

5.2 Infectious Diseases 55

5.3 Oncology 56

5.4 Ophthalmology 57

5.5 Cardiovascular Disorders 58

5.6 Central Nervous System 59

5.7 Respiratory Disorders 60

5.8 Metabolic Diseases 61

5.9 Other Applications 62

6 Segmentation of Global Market by Application 63

6.1 Market Overview by Application 63

6.2 Clinical Use 65

6.3 Commercial Use 66

7 Segmentation of Global Market by Manufacturer Type 67

7.1 Market Overview by Manufacturer Type 67

7.2 Pharmaceutical Companies 69

7.3 CMOs 71

8 Segmentation of Global Market by Region 73

8.1 Geographic Market Overview 2020-2027 73

8.2 North America Market 2020-2027 by Country 77

8.2.1 Overview of North America Market 77

8.2.2 U.S. 80

8.2.3 Canada 84

8.2.4 Mexico 86

8.3 European Market 2020-2027 by Country 88

8.3.1 Overview of European Market 88

8.3.2 UK 91

8.3.3 France 93

8.3.4 Germany 95

8.3.5 Spain 97

8.3.6 Italy 99

8.3.7 Russia 101

8.3.8 Rest of European Market 103

8.4 Asia-Pacific Market 2020-2027 by Country 105

8.4.1 Overview of Asia-Pacific Market 105

8.4.2 China 108

8.4.3 Japan 110

8.4.4 India 113

8.4.5 Australia 115

8.4.6 South Korea 117

8.4.7 Rest of APAC Region 119

8.5 South America Market 2020-2027 by Country 121

8.5.1 Argentina 124

8.5.2 Brazil 126

8.5.3 Chile 128

8.5.4 Rest of South America Market 130

8.6 MEA Market 2020-2027 by Country 131

8.6.1 UAE 134

8.6.2 Saudi Arabia 136

8.6.3 South Africa 138

8.6.4 Other National Markets 140

9 Competitive Landscape 141

9.1 Overview of Key Vendors 141

9.2 New Product Launch, Partnership, Investment, and M&A 144

9.3 Company Profiles 145

Aurobindo Pharma Ltd. 145

Cambrex Corporation 147

Catalent, Inc. 148

Dr. Reddy's Laboratories Ltd. 149

GlaxoSmithKline plc 150

Lonza Group 151

Merck & Co., Inc. 152

Mylan N.V. 153

Novartis AG 154

Pfizer Inc. 155

Sun Pharmaceutical Industries Ltd. 156

Teva Pharmaceutical Industries Ltd. 157

Wuxi AppTec Co., Ltd. 158

10 Investing in Global Market: Risk Assessment and Management 159

10.1 Risk Evaluation of Global Market 159

10.2 Critical Success Factors (CSFs) 162

Related Reports and Products 165


List Of Figure

Figure 1. Research Method Flow Chart 12

Figure 2. Breakdown of Primary Research 14

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 16

Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 18

Figure 5. Global Small Molecule API Market, 2017-2027, USD mn 21

Figure 6. Impact of COVID-19 on Business 24

Figure 7. Primary Drivers and Impact Factors of Global Small Molecule API Market 26

Figure 8. Primary Restraints and Impact Factors of Global Small Molecule API Market 29

Figure 9. Investment Opportunity Analysis 33

Figure 10. Porter's Fiver Forces Analysis of Global Small Molecule API Market 36

Figure 11. Breakdown of Global Small Molecule API Market by Source, 2020-2027, % of Revenue 40

Figure 12. Contribution to Global 2021-2027 Cumulative Revenue by Source, Value (USD mn) and Share (%) 41

Figure 13. Global Small Molecule API Market: Synthetic API, 2017-2027, USD mn 42

Figure 14. Global Small Molecule API Market: Branded Synthetic API, 2017-2027, USD mn 43

Figure 15. Global Small Molecule API Market: Generic Synthetic API, 2017-2027, USD mn 44

Figure 16. Global Small Molecule API Market: Semi-synthetic API, 2017-2027, USD mn 45

Figure 17. Global Small Molecule API Market: Natural Origin, 2017-2027, USD mn 46

Figure 18. Breakdown of Global Small Molecule API Market by Type, 2020-2027, % of Revenue 47

Figure 19. Contribution to Global 2021-2027 Cumulative Revenue by Type, Value (USD mn) and Share (%) 48

Figure 20. Global Small Molecule API Market: Standard API, 2017-2027, USD mn 49

Figure 21. Global Small Molecule API Market: High Potency API (HPAPI), 2017-2027, USD mn 50

Figure 22. Global Small Molecule API Market: Branded HPAPI, 2017-2027, USD mn 51

Figure 23. Global Small Molecule API Market: Generic HPAPI, 2017-2027, USD mn 52

Figure 24. Breakdown of Global Small Molecule API Market by Therapeutic Area, 2020-2027, % of Revenue 54

Figure 25. Contribution to Global 2021-2027 Cumulative Revenue by Therapeutic Area, Value (USD mn) and Share (%) 54

Figure 26. Global Small Molecule API Market: Infectious Diseases, 2017-2027, USD mn 55

Figure 27. Global Small Molecule API Market: Oncology, 2017-2027, USD mn 56

Figure 28. Global Small Molecule API Market: Ophthalmology , 2017-2027, USD mn 57

Figure 29. Global Small Molecule API Market: Cardiovascular Disorders, 2017-2027, USD mn 58

Figure 30. Global Small Molecule API Market: Central Nervous System, 2017-2027, USD mn 59

Figure 31. Global Small Molecule API Market: Respiratory Disorders, 2017-2027, USD mn 60

Figure 32. Global Small Molecule API Market: Metabolic Diseases, 2017-2027, USD mn 61

Figure 33. Global Small Molecule API Market: Other Applications, 2017-2027, USD mn 62

Figure 34. Breakdown of Global Small Molecule API Market by Application, 2020-2027, % of Revenue 63

Figure 35. Contribution to Global 2021-2027 Cumulative Revenue by Application, Value (USD mn) and Share (%) 64

Figure 36. Global Small Molecule API Market: Clinical Use, 2017-2027, USD mn 65

Figure 37. Global Small Molecule API Market: Commercial Use, 2017-2027, USD mn 66

Figure 38. Breakdown of Global Small Molecule API Market by Manufacturer Type, 2020-2027, % of Revenue 67

Figure 39. Contribution to Global 2021-2027 Cumulative Revenue by Manufacturer Type, Value (USD mn) and Share (%) 68

Figure 40. Global Small Molecule API Market: Pharmaceutical Companies, 2017-2027, USD mn 69

Figure 41. Breakdown of Global Small Molecule API In-house Synthesis Market by Region, 2020-2027, % of Revenue 70

Figure 42. Global Small Molecule API Market: CMOs, 2017-2027, USD mn 71

Figure 43. Breakdown of Global Small Molecule API Contract Synthesis Market by Region, 2020-2027, % of Revenue 72

Figure 44. Global Market Snapshot by Region 73

Figure 45. Geographic Spread of Worldwide Small Molecule API Market, 2020-2027, % of Revenue 74

Figure 46. Contribution to Global 2021-2027 Cumulative Revenue by Region, Value (USD mn) and Share (%) 75

Figure 47. North American Small Molecule API Market, 2017-2027, USD mn 78

Figure 48. Breakdown of North America Small Molecule API Market by Country, 2020 and 2027, % of Revenue 78

Figure 49. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 79

Figure 50. U.S. Small Molecule API Market, 2017-2027, USD mn 81

Figure 51. Canada Small Molecule API Market, 2017-2027, USD mn 84

Figure 52. Small Molecule API Market in Mexico, 2017-2027, USD mn 86

Figure 53. European Small Molecule API Market, 2017-2027, USD mn 89

Figure 54. Breakdown of European Small Molecule API Market by Country, 2020 and 2027, % of Revenue 89

Figure 55. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 90

Figure 56. Small Molecule API Market in UK, 2017-2027, USD mn 91

Figure 57. Small Molecule API Market in France, 2017-2027, USD mn 93

Figure 58. Small Molecule API Market in Germany, 2017-2027, USD mn 95

Figure 59. Small Molecule API Market in Spain, 2017-2027, USD mn 97

Figure 60. Small Molecule API Market in Italy, 2017-2027, USD mn 99

Figure 61. Small Molecule API Market in Russia, 2017-2027, USD mn 101

Figure 62. Small Molecule API Market in Rest of Europe, 2017-2027, USD mn 103

Figure 63. Asia-Pacific Small Molecule API Market, 2017-2027, USD mn 106

Figure 64. Breakdown of APAC Small Molecule API Market by Country, 2020 and 2027, % of Revenue 106

Figure 65. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 107

Figure 66. Small Molecule API Market in China, 2017-2027, USD mn 108

Figure 67. Small Molecule API Market in Japan, 2017-2027, USD mn 111

Figure 68. Small Molecule API Market in India, 2017-2027, USD mn 113

Figure 69. Small Molecule API Market in Australia, 2017-2027, USD mn 115

Figure 70. Small Molecule API Market in South Korea, 2017-2027, USD mn 117

Figure 71. Small Molecule API Market in Rest of APAC, 2017-2027, USD mn 119

Figure 72. South America Small Molecule API Market, 2017-2027, USD mn 122

Figure 73. Breakdown of South America Small Molecule API Market by Country, 2020 and 2027, % of Revenue 122

Figure 74. Contribution to South America 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 123

Figure 75. Small Molecule API Market in Argentina, 2017-2027, USD mn 124

Figure 76. Small Molecule API Market in Brazil, 2017-2027, USD mn 126

Figure 77. Small Molecule API Market in Chile, 2017-2027, USD mn 128

Figure 78. Small Molecule API Market in Rest of South America, 2017-2027, USD mn 130

Figure 79. Small Molecule API Market in Middle East and Africa (MEA), 2017-2027, USD mn 132

Figure 80. Breakdown of MEA Small Molecule API Market by Country, 2020 and 2027, % of Revenue 132

Figure 81. Contribution to MEA 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 133

Figure 82. Small Molecule API Market in UAE, 2017-2027, USD mn 134

Figure 83. Small Molecule API Market in Saudi Arabia, 2017-2027, USD mn 136

Figure 84. Small Molecule API Market in South Africa, 2017-2027, USD mn 138

Figure 85. Growth Stage of Global Small Molecule API Industry over the Forecast Period 141


List Of Table

Table 1. Snapshot of Global Small Molecule API Market in Balanced Perspective, 2020-2027 19

Table 2. Growth Rate of World GDP, 2020-2022 23

Table 3. Main Product Trends and Market Opportunities in Global Small Molecule API Market 32

Table 4. Global Small Molecule API Market by Source, 2017-2027, USD mn 40

Table 5. Global Small Molecule API Market: Synthetic API by Drug Type, 2017-2027, USD mn 42

Table 6. Global Small Molecule API Market by Type, 2017-2027, USD mn 47

Table 7. Global Small Molecule API Market: HPAPI by Drug Type, 2017-2027, USD mn 50

Table 8. Global Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 53

Table 9. Global Small Molecule API Market by Application, 2017-2027, USD mn 63

Table 10. Global Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 67

Table 11. Global Small Molecule API Market by Region, 2017-2027, USD mn 74

Table 12. Leading National Small Molecule API Market, 2020 and 2027, USD mn 76

Table 13. North America Small Molecule API Market by Country, 2017-2027, USD mn 79

Table 14. U.S. Small Molecule API Market by Type, 2017-2027, USD mn 82

Table 15. U.S. Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 82

Table 16. U.S. Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 82

Table 17. Canada Small Molecule API Market by Type, 2017-2027, USD mn 85

Table 18. Canada Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 85

Table 19. Canada Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 85

Table 20. Mexico Small Molecule API Market by Type, 2017-2027, USD mn 87

Table 21. Mexico Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 87

Table 22. Mexico Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 87

Table 23. Europe Small Molecule API Market by Country, 2017-2027, USD mn 90

Table 24. UK Small Molecule API Market by Type, 2017-2027, USD mn 92

Table 25. UK Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 92

Table 26. UK Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 92

Table 27. France Small Molecule API Market by Type, 2017-2027, USD mn 94

Table 28. France Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 94

Table 29. France Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 94

Table 30. Germany Small Molecule API Market by Type, 2017-2027, USD mn 96

Table 31. Germany Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 96

Table 32. Germany Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 96

Table 33. Spain Small Molecule API Market by Type, 2017-2027, USD mn 98

Table 34. Spain Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 98

Table 35. Spain Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 98

Table 36. Italy Small Molecule API Market by Type, 2017-2027, USD mn 100

Table 37. Italy Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 100

Table 38. Italy Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 100

Table 39. Russia Small Molecule API Market by Type, 2017-2027, USD mn 102

Table 40. Russia Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 102

Table 41. Russia Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 102

Table 42. Small Molecule API Market in Rest of Europe by Country, 2017-2027, USD mn 104

Table 43. APAC Small Molecule API Market by Country, 2017-2027, USD mn 107

Table 44. China Small Molecule API Market by Type, 2017-2027, USD mn 109

Table 45. China Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 109

Table 46. China Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 109

Table 47. Japan Small Molecule API Market by Type, 2017-2027, USD mn 112

Table 48. Japan Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 112

Table 49. Japan Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 112

Table 50. India Small Molecule API Market by Type, 2017-2027, USD mn 114

Table 51. India Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 114

Table 52. India Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 114

Table 53. Australia Small Molecule API Market by Type, 2017-2027, USD mn 116

Table 54. Australia Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 116

Table 55. Australia Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 116

Table 56. South Korea Small Molecule API Market by Type, 2017-2027, USD mn 118

Table 57. South Korea Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 118

Table 58. South Korea Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 118

Table 59. Small Molecule API Market in Rest of APAC by Country/Region, 2017-2027, USD mn 120

Table 60. South America Small Molecule API Market by Country, 2017-2027, USD mn 123

Table 61. Argentina Small Molecule API Market by Type, 2017-2027, USD mn 125

Table 62. Argentina Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 125

Table 63. Argentina Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 125

Table 64. Brazil Small Molecule API Market by Type, 2017-2027, USD mn 127

Table 65. Brazil Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 127

Table 66. Brazil Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 127

Table 67. Chile Small Molecule API Market by Type, 2017-2027, USD mn 129

Table 68. Chile Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 129

Table 69. Chile Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 129

Table 70. MEA Small Molecule API Market by Country, 2017-2027, USD mn 133

Table 71. UAE Small Molecule API Market by Type, 2017-2027, USD mn 135

Table 72. UAE Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 135

Table 73. UAE Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 135

Table 74. Saudi Arabia Small Molecule API Market by Type, 2017-2027, USD mn 137

Table 75. Saudi Arabia Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 137

Table 76. Saudi Arabia Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 137

Table 77. South Africa Small Molecule API Market by Type, 2017-2027, USD mn 139

Table 78. South Africa Small Molecule API Market by Therapeutic Area, 2017-2027, USD mn 139

Table 79. South Africa Small Molecule API Market by Manufacturer Type, 2017-2027, USD mn 139

Table 80. Aurobindo Pharma Ltd.: Company Snapshot 145

Table 81. Aurobindo Pharma Ltd.: Business Segmentation 145

Table 82. Aurobindo Pharma Ltd.: Product Portfolio 146

Table 83. Aurobindo Pharma Ltd.: Revenue, 2017-2019, USD mn 146

Table 84. Risk Evaluation for Investing in Global Market, 2020-2027 160

Table 85. Critical Success Factors and Key Takeaways 163

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Aurobindo Pharma Ltd.

Cambrex Corporation

Catalent, Inc.

Dr. Reddy's Laboratories Ltd.

GlaxoSmithKline plc

Lonza Group

Merck & Co., Inc.

Mylan N.V.

Novartis AG

Pfizer Inc.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Wuxi AppTec Co., Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)